Signaling Pathways - Selective - Acute Myelogenous Leukemia - Inflammatory Diseases - Multidrug Resistance Studies
清除全部
-
B4877 URMC-099Target: MLK3Summary: MLK3抑制剂 -
B7787 PMX 205 TrifluoroacetateTarget: C5a receptorsSummary: C5a受体肽拮抗剂 -
B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂 -
B5612 BAY 60-6583Target: Adenosine A2B ReceptorsSummary: A2B受体的强效激动剂 -
B5321 DOI hydrochlorideTarget: 5-HT2 ReceptorsSummary: 脑通透性、混合型5-HT2A/5-HT2C受体激动剂 -
B5549 PF-3644022Target: MK2Summary: MK2抑制剂 -
B5298 ABT 702 dihydrochlorideTarget: Adenosine KinasesSummary: 腺苷激酶抑制剂 -
B7443 (5Z)-7-Oxozeaenol1 CitationTarget: TAK1Summary: TAK1促分裂原活化蛋白激酶激酶激酶（MAPKKK）抑制剂 -
B7023 MK-571Target: Leukotriene and Related ReceptorsSummary: leukotriene D4（LTD4)受体拮抗剂 -
B7005 Prostaglandin E2中文名: 前列腺素E2Target: Prostaglandin EP receptorsSummary: 内源性前列腺素